<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fibrillin is the major component of extracellular microfibrils </plain></SENT>
<SENT sid="1" pm="."><plain>Mutations in the fibrillin gene on chromosome 15 (FBN1) were described at first in the <z:e sem="disease" ids="C0410787" disease_type="Disease or Syndrome" abbrv="">heritable connective tissue disorder</z:e>, <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>More recently, FBN1 has also been shown to harbor mutations related to a spectrum of conditions phenotypically related to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>These mutations are private, essentially missense, generally non-recurrent and widely distributed throughout the gene </plain></SENT>
<SENT sid="4" pm="."><plain>To date no clear genotype/phenotype relationship has been observed excepted for the localization of neonatal mutations in a cluster between exons 24 and 32 </plain></SENT>
<SENT sid="5" pm="."><plain>The second version of the computerized Marfan database contains 89 entries </plain></SENT>
<SENT sid="6" pm="."><plain>The software has been modified to accomodate new functions and routines </plain></SENT>
</text></document>